Abstract:Diabetic ulcers (DUs) present significant physical and psychological challenges to patients, while placing a significant economic burden on healthcare systems. Promoting the blood vessel regeneration is critical for ensuring the delivery of essential nutrients and oxygen to the injured area, thereby supporting the healing process. To gain insight into the complex molecular mechanisms that drive DUs healing, we performed a comprehensive analysis of single-cell transcriptomic data from healing and non-healing DU states. This analysis revealed a key role of Schlafen5 (SLFN5) signal in modulating key healing processes. SLFN5, a protein known to regulate cellular processes like migration, invasion, inflammation, and cell death, emerged as an important player. Yet, although it is prominent, the specific function of SLFN5 in diabetic skin wounds remained unclear. Our study discovered a marked elevation of SLFN5 levels in endothelial cells within DUs and its suppression notably mitigates the oxidative stress and endoplasmic reticulum stress (ERS)-mediated cell death pathways, including pyroptosis and apoptosis. This finding implies that excessive SLFN5 activity might obstruct wound closure by intensifying cellular stress reactions. Upon further investigation, we found that the antioxidant and cytoprotective effects were mediated through enhanced NRF2 activity, facilitated by the PI3K/Akt signaling pathway. Moreover, our investigation identified that c-Fos as a pivotal transcription factor governing SLFN5 transcription during the development of DUs, offering valuable insights into the regulation of SLFN5 expression. In diabetic mice model, SLFN5 knockdown accelerating wound healing, which was intervened by PI3K/Akt inhibitor. These results hold significant therapeutic potential, indicating that targeting SLFN5 may represent a novel and effective strategy for improving wound healing outcomes in patients with DUs.

The Schlafen family: complex roles in different cell types and virus replication

Structural, molecular, and functional insights into Schlafen proteins

Research progress of the SLFN family in malignant tumors

Progress in investigating the relationship between Schlafen5 genes and malignant tumors

Expression of Schlafen2 Gene and Its Effect on NIH/3T3 Cells

Human Schlafen 11 exploits codon preference discrimination to attenuate viral protein synthesis of prototype foamy virus (PFV)

Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity

Mouse Slfn8 and Slfn9 genes complement human cells lacking SLFN11 during the replication stress response

Schlafen 11 triggers innate immune responses through its ribonuclease activity upon detection of single-stranded DNA

Schlafen-5 inhibits LINE-1 retrotransposition

The Hsp40 Family Chaperone Protein DnaJB6 Enhances Schlafen1 Nuclear Localization Which is Critical for Promotion of Cell-Cycle Arrest in T-cells.

Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets: A Study of 127 Entities Represented by 6658 Tumors

Schlafen-11 and -9 are innate immune sensors for intracellular single-stranded DNA

Schlafen14 Impairs HIV-1 Expression in a Codon Usage-Dependent Manner

Waking the sleeping giant: Single-stranded DNA binds Schlafen 11 to initiate innate immune responses

Recurrent Evolutionary Innovations in Rodent and Primate Genes

Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma

Schlafen5, regulated by the AP-1 family transcription factor c-Fos, affects diabetic wound healing through modulating PI3K/Akt/NRF2 axis

The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer

A review: Mechanisms and molecular pathways of signaling lymphocytic activation molecule family 3 (SLAMF3) in immune modulation and therapeutic prospects

The Role of the Slit/Robo Signaling Pathway